Page last updated: 2024-08-21

erythromycin and Hemorrhage, Peptic Ulcer

erythromycin has been researched along with Hemorrhage, Peptic Ulcer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botargues, JM; Brullet Benedi, E; Calvet Calvo, X; Campo Fernández de Los Ríos, R; Cánovas Moreno, G; Feu Caballé, F; Fort Martorell, E; Gallach Montero, M; García-Iglesias, P; Gené Tous, E; Hidalgo Rosas, JM; Lago Macía, A; Nieto Rodríguez, A; Papo Berger, M; Planella de Rubinat, M; Saló Rich, J; Villanueva Sánchez, C1
Jensen, DM; Kovacs, TO1
Jensen, DM; Laine, L1

Reviews

2 review(s) available for erythromycin and Hemorrhage, Peptic Ulcer

ArticleYear
Endoscopic therapy for severe ulcer bleeding.
    Gastrointestinal endoscopy clinics of North America, 2011, Volume: 21, Issue:4

    Topics: Combined Modality Therapy; Electrocoagulation; Endoscopy, Gastrointestinal; Epinephrine; Erythromycin; Hemostasis, Endoscopic; Humans; Hyperthermia, Induced; Peptic Ulcer Hemorrhage; Resuscitation; Risk Assessment; Surgical Instruments; Tissue Adhesives; Ultrasonography, Doppler

2011
Management of patients with ulcer bleeding.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:3

    Topics: Blood Transfusion; Clinical Trials as Topic; Endoscopy, Gastrointestinal; Erythromycin; Evidence-Based Medicine; Fluid Therapy; Gastric Lavage; Hemostasis, Endoscopic; Humans; Meta-Analysis as Topic; Patient Selection; Peptic Ulcer Hemorrhage; Prognosis; Proton Pump Inhibitors; Resuscitation; Retreatment; Risk Assessment; Secondary Prevention

2012

Other Studies

1 other study(ies) available for erythromycin and Hemorrhage, Peptic Ulcer

ArticleYear
Management of non variceal upper gastrointestinal bleeding: position statement of the Catalan Society of Gastroenterology.
    Gastroenterologia y hepatologia, 2017, Volume: 40, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Biomarkers; Combined Modality Therapy; Comorbidity; Contraindications, Drug; Crystalloid Solutions; Disease Management; Endoscopy, Gastrointestinal; Erythrocyte Transfusion; Erythromycin; Helicobacter Infections; Helicobacter pylori; Hemostatic Techniques; Humans; Hypotension; Intubation, Gastrointestinal; Isotonic Solutions; Liver Cirrhosis; Peptic Ulcer Hemorrhage; Physical Examination; Recurrence; Risk Factors; Vitamin K

2017